FDA issues seafood facilities HACCP warning letters

'Serious violations' found at facilities of New York and Brazilian companies.

The Food and Drug Administration (FDA) recently issued two seafood companies warning letters regarding violations of seafood Hazard Analysis and Critical Control Point (HACCP) regulations.

The FDA found "serious violations" after inspecting the facility of New York-based seafood importer CK Frozen Fish and Food Inc. on Jan. 6.

The agency stated in its letter the imported "did not implement an affirmative step for Frozen Dry Keski" in accordance with the seafood HACCP Regulation.

The FDA also inspected a facility of Brazilian seafood processor Atum Do Brasil Captura Industria e Comercio last October, also finding "serious violations."

The FDA told Atum Do Brasil it found issues with the company's HACCP plan for “Fresh Fish Filets” as it does not list the food safety hazard of Clostridium botulinum toxin formation among other critical control points.

However, the company responded to the FDA last October and December saying it took corrective actions, notified the Brazilian Ministry of Agriculture and revised its HACCP plans.

Upon review of these responses, the FDA said the "revised plans revealed serious deviations from the requirements of the seafood HACCP regulation."


For more seafood news and updates, follow us on Facebook and Twitter or sign up for our daily newsletter